A Breakthrough in Pain Management: Inside the Promise of Journavx
Risk & Insurance - Apr 03, 2025
Enlyte’s Nikki Wilson offers a fresh take on a promising alternative to opioids, a first-of-its-kind FDA-approved non-addictive medication for pain. The post A Breakthrough in Pain Management: Inside the Promise of Journavx appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Nov 09, 2025
Buyers of professional lines coverage face favorable pricing, even as socio-economic factors could l...
Posted: Nov 08, 2025
Evolution in taking every aspect of an injured worker's wellbeing into consideration is ongoing in w...
Posted: Nov 07, 2025
The latest people news in the industry today. The post Nikole Alcala Promoted to Associate Vice Pres...